Percutaneous Approaches to the Treatment of Mitral Leaflet Perforation and to Residual Regurgitation After Transcatheter Edge-to-Edge Mitral Valve Repair

Authors

Marvin H. Eng, Henry Ford HealthFollow
Tiberio M. Frisoli, Henry Ford HealthFollow
Adam B. Greenbaum
Pedro Villablanca, Henry Ford HealthFollow
Dee Dee Wang, Henry Ford HealthFollow
James Lee, Henry Ford HealthFollow
William O'Neill, Henry Ford HealthFollow

Recommended Citation

Eng MH, Frisoli TM, Greenbaum AB, Villablanca P, Wang DD, Lee J, and O'Neill W. Percutaneous Approaches to the Treatment of Mitral Leaflet Perforation and to Residual Regurgitation After Transcatheter Edge-to-Edge Mitral Valve Repair. Interv Cardiol Clin 2019; 8(4):383-391.

Document Type

Article

Publication Date

10-1-2019

Publication Title

Interv Cardiol Clin

Abstract

Mitral valve disease becomes more prevalent as the population ages. As the number of percutaneous mitral valve interventions expands, obscure clinical scenarios may emerge and challenge conventional treatment algorithms. Strategies for dealing with complex repairs build on prior experience in mitral perivalvular leak repair. Cases using nitinol- and expanded polytetrafluoroethylene-based devices are used to treat mitral regurgitation in cases of focal mitral perforations and leaks between previously placed mitral valve edge-to-edge devices. This review discusses risks and benefits of performing such complex mitral repairs and informs clinicians of the strengths of weaknesses of different occluder devices in the mitral position.

PubMed ID

31445722

Volume

8

Issue

4

First Page

383

Last Page

391